New Quantum Approach on Epilepsy Drug 3'-Aminothymidin Based on Pharmacokinetic, Topological and Molecular Docking Report

In recent years, agricultural development has been one of the most significant initiatives. When introducing a product, it is essential to take into account clinical testing using ADMET qualities, pharmacokinetic properties, topological area, mass spectral analysis, and a report on microspecies dispersion. The creation of in silico models has been hampered by the desire of bio researchers. Pharmacokinetic properties control the amount of agricultural products consumed and how the body handles drugs. The current DFT research will help the biological industry adopt a new strategy for drug development. We investigated various aspects of the drug azidothymidine (AZDM). A variety of useful azidothymidine production values were discovered after further research into the docking results against two protein targets of the SNX2 gene for their antiepileptic activity.